About 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide
2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide (PubChem CID 2225018) has the molecular formula C16H13BrN4O2S
and a molecular weight of 405.28 g/mol. Its IUPAC name is 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide.
Analyze 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide?
The IUPAC name of 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide (CID 2225018) is 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide.
What is the SMILES notation for 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide?
The canonical SMILES for 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide is O=C(CSc1nnc(Cc2ccccc2)o1)Nc1ccc(Br)cn1.
What is the InChIKey of 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide?
The InChIKey is QUCLKTJKSXUTRY-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H13BrN4O2S/c17-12-6-7-13(18-9-12)19-14(22)10-24-16-21-20-15(23-16)8-11-4-2-1-3-5-11/h1-7,9H,8,10H2,(H,18,19,22).
What are the key properties of 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide?
2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide has a molecular weight of 405.28 g/mol, XLogP of 3.55, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5-benzyl-1,3,4-oxadiazol-2-yl)sulfanyl]-N-(5-bromo-2-pyridinyl)acetamide is sourced from PubChem (CID 2225018), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).